1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NIH Accelerator Program is sponsored by National Institutes of Health (NIH) (Collaborative effort with Prisma Health Education and Research Institute, Clemson University, University of South Carolina School of Medicine Greenville, and the Addiction Medicine Center). This is an intensive mentoring program for faculty investigators seeking NIH funding.
The program aims to strategically position early-career investigators to develop complete and competitive NIH grant applications.
Get alerted about grants like this
Get emailed when new opportunities from “National Institutes of Health (NIH) (Collaborative effort with Prisma Health Education and Research Institute, Clemson University, University of South Carolina School of Medicine Greenville, and the Addiction Medicine Center)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
The NIH Accelerator Program was developed as a collaborative effort among Prisma Health Education and Research Institute, Clemson University, the University of South Carolina School of Medicine Greenville and the Addiction Medicine Center. The NIH Accelerator Program is an intensive mentoring program for faculty investigators seeking NIH funding.
The aim of the program is to strategically position early-career investigators from Prisma Health Education and Research Institute partner institutions,so that by the end of the program each participant will have a complete and competitive NIH grant application. During this program, mentors and mentees will meet bi-monthly to discuss, present,and provide feedback on sections of each mentee’s grant proposal.
For more information, consult the Program Description, Goals and Structure document and the Cohort 7 NIH Accelerator Program flyer. Check out an article about the program published by Clemson News. Questions may be directed to Ashley King.
Application window closes on**August 2, 2026 at 10:00 p. m. ** Interested applicants must: 1.
Complete the online application 2.
Send an updated CV of the applicant to Ashley King Applicants are strongly recommended to align their proposal with Clemson Elevate focus areas and/or Prisma Health-Clemson focus areas: * Human Factors and Human Performance * Health System Research / Care Delivery Innovations * Community and Public Health * Addiction and Substance Use Disorders and Mental Health * Safety, Quality, and Patient Experience * Emerging Infectious Diseases Please be aware that the applicant’s primary mentor will be encouraged to attend when the mentee is presenting.
The applicant should plan ahead and work with their primary mentor to ensure that this is possible. **Application window closes |**Sunday, August 2, 2026 **Applicants notified of status |** Friday August 14, 2026* **Program schedule notification |**Friday August 21, 2026* **Program begins |** Week of September 7, 2026* _*Dates are subject to change. _
According to the current listing, eligibility includes: Faculty investigators from Prisma Health Education and Research Institute partner institutions, Clemson University, and the University of South Carolina School of Medicine Greenville, seeking NIH funding. Confirm the full requirements in the official notice before applying.
The published deadline was August 2, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
NIH Accelerator Program is funded by National Institutes of Health (NIH) (Collaborative effort with Prisma Health Education and Research Institute, Clemson University, University of South Carolina School of Medicine Greenville, and the Addiction Medicine Center). Verify program details on the funder's official page before applying.
This opportunity targets applicants in South Carolina. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleNIH's 271% year-over-year jump in early-cycle multiyear awards — 601 grants worth $402M obligated by mid-May 2026 vs. 162 grants and $79M at the same point in 2025 — is shrinking the pool available for new R01s, R21s, and K-awards. The FY2027 budget request asks Congress to make the practice the default. Researchers need to model the squeeze, not assume it away.
Read articleNIH's June 1 omnibus reset added Direct-to-Phase II to the STTR program for the first time. The change compresses university spinouts' funding timeline from three years to fifteen months, but the 30% research-institution subaward, feasibility-evidence rules, and IP licensing mechanics are not yet sorted at most universities.
Read article